Bill Text: US HB7667 | 2021-2022 | 117th Congress | Engrossed
Bill Title: Biosimilar User Fee Amendments of 2022 Generic Drug User Fee Amendments of 2022 Prescription Drug User Fee Amendments of 2022 Medical Device User Fee Amendments of 2022
Spectrum: Bipartisan Bill
Status: (Engrossed - Dead) 2022-06-09 - Received in the Senate. [HB7667 Detail]
Download: US_Congress-2021-HB7667-Engrossed.pdf